Dual clinical studies reveal statistically meaningful benefits for patients with MSA, highlighting a leap forward for disease-modifying treatment …
Dual clinical studies reveal statistically meaningful benefits for patients with MSA, highlighting a leap forward for disease-modifying treatment …
New research unveiled at the American Association for Cancer Research meeting points to promising treatments for head and …
Zydus’ experimental therapy demonstrates significant improvements in liver function and patient outcomes, signaling new hope in a disease …
New safety and efficacy evidence supports expanded use of mavacamten in oHCM patients
On 15 April 2025, the European Medicines Regulatory Network rolled out an interactive trial map—empowering patients and professionals …
Targeted treatment approach shows potential to reshape how antidepressants are prescribed
Fresh guidelines and a reshaped regulatory framework pave the way for smoother clinical research, even as COVID-19 maintains …
An investigational RNA-based therapy shows significant reduction in disease-causing protein levels—potentially a meaningful step forward in treating Huntington’s …
Topical laquinimod reaches posterior eye tissues with dose-related distribution and good tolerability in patients preparing for vitrectomy
Early-stage data reveal tumour targeting and tolerability with radiolabelled GRPR antagonist therapy in metastatic prostate cancer
Already a subscriber? Log in